首页 > 市场调查报告书 > 製药

生长激素市场:剂型，各用途，各流通管道，各地区-规模，占有率，展望，机会分析，2023年～2030年

市场调查报告书

商品编码

1349825

生长激素市场:剂型，各用途，各流通管道，各地区-规模，占有率，展望，机会分析，2023年～2030年

Somatropin Market, By Dosage Form, By Application, By Distribution Channel, and By Region (North America, Latin America, Europe, Asia Pacific, Middle East and Africa)-Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

出版日期: 2023年07月27日 | 出版商:

Coherent Market Insights | 英文 240 Pages | 商品交期: 2-3个工作天内

价格

简介目录

预估 2023 年全球生长激素市场价值 38.5 亿美元，预测期内（2023-2030 年）复合年增长率为 7.3%。

报告范围		报告详细资料
基准年	2022	2023 年市场规模	美国：38.5亿美元
过去的资料	2018年至2021年	预测期间	2023-2030
预测 2023-2030 年复合年增长率：	7.30%	2030年价值预测	63亿美元

生长激素注射液用于取代患有生长激素缺乏症的成人和儿童的生长激素（体内产生的天然激素）。生长激素注射液也用于促进患有某些影响正常生长和发育的疾病的儿童的生长。生长激素注射剂以溶液（液体）形式装在预先装载的剂量笔或药筒中，或以粉末形式装在小瓶或药筒中，与液体混合并皮下注射（皮下）。当生长激素注射剂用于取代成人生长激素时，通常每天注射一次。生长激素注射液（Serostim）用于增加患有爱滋病毒相关消耗症候群的人类免疫缺陷病毒（HIV）患者的体重和身体耐力。生长激素注射液（Zolbutib）用于治疗透过静脉治疗接受额外营养或液体的成人短肠症候群。Somatropin 是一种人类生长激素 (hGH) 类似物。它的作用是取代体内正常产生的生长激素，从而促进生长、体重增加以及改善肠道对营养和水分的吸收。当注射生长激素来取代生长激素或促进儿童生长时，通常每天注射一次，每週注射 3 至 7 天。监管机构增加产品上市和产品批准，提高生长激素治疗对生长激素缺乏儿童的长期疗效，预计将在预测期内推动全球生长激素市场的成长。

市场动态

监管产品核准的增加以及生长激素缺乏儿童生长激素治疗的长期疗效预计将在预测期内推动全球生长激素市场的成长。例如，生产药品的 Ascendis Pharma A/S 公司于 2022 年 1 月被欧盟委员会（EC）诊断为因内源性生长激素分泌不足而促使生长缺陷（又称生长激素缺乏症，GHD）。该公司宣布，其Lonapegsomatropin Ascendis Pharma（以TransCon hGH 名称开发）已获得上市批准，作为每週一次的皮下注射剂，用于治疗3 至18 岁的儿童和青少年。TransCon hGH 是一种生长激素前药，可在体内以治疗水平持续释放未修饰的生长激素 (hGH)。

本调查的主要特征

本报告提供以2022年为基准年的预测期间（2023-2030 年）之全球生长激素市场的市场规模和復合年增长率（CAGR %）相关的详区隔析。
并阐明不同部门市场的潜在收入机会，说明该市场具有魅力的投资主张矩阵。
同时并提供市场推动因素和限制、机会、新产品发布或批准、市场趋势、区域前景和主要参与者采用的竞争战略等重要考察。
并基于企业亮点，各类型投资组合、主要焦点、财务业绩和市场策略等参数，介绍全球生长激素市场的主要参与者之企业简介。
藉由该报告提供的洞察，将能帮助营销人员和公司高管能够就未来的产品发布、类型升级、市场扩张和营销策略做出明智的决策。
全球生长激素市场报告配合该行业的各种利益相关者，包括投资者、供应商、产品製造商、分销商、新进入者和金融分析师。
利益相关者可以透过全球生长激素市场用于分析的各种战略矩阵来帮助他们更容易做下决策。

Novo Nordisk A/S
Pfizer, Inc.
Eli Lilly and Company
Changchun GeneScience Pharmaceutical Co., Ltd.
Sandoz International GmbH
Ipsen Pharma
LG Chem
Merck KGaA
Genentech, Inc.
Ferring B.V.
AnkeBio Co., Ltd
Reliance Life Sciences
JCR Pharmaceuticals Co., Ltd
Zhongshan Sinobioway Hygene Biomedicine Co., Ltd
USV Private Limited

第10章章节

调查手法
关于出版社

简介目录

Product Code: CMI4062

Global somatropin market is estimated to be valued at US$ 3.85 Billion in 2023 and is expected to exhibit a CAGR of 7.3% during the forecast period (2023-2030).

Report Coverage		Report Details
Base Year:	2022	Market Size in 2023:	US$ 3.85 Bn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	7.30%	2030 Value Projection:	US$ 6.30 Bn

Somatropin injections are used to replace growth hormone (a natural hormone produced by the body) in adults and children with growth hormone deficiency. Somatropin injections are also used to increase growth in children with certain conditions that affect normal growth and development. Somatropin injection comes as a solution (liquid) in prefilled dosing pens and cartridges and also as a powder in vials and cartridges to be mixed with liquid to be injected subcutaneously (under the skin). When somatropin injections are given to replace growth hormone in adults, it is usually given once a day. Somatropin injections (Serostim) are used to increase body weight and physical endurance in patients with the human immunodeficiency virus (HIV) who have HIV-associated wasting syndrome. Somatropin injections (Zorbtive) are used to treat short bowel syndrome in adults who are receiving additional nutrition or fluids from intravenous (IV) therapy. Somatropin is a human growth hormone (hGH) analog. It works by replacing growth hormones that are normally produced in the body, which may result in increased growth, body weight, and improved absorption of nutrients and fluids from the intestines. When somatropin injection to replace growth hormone or increase growth in children, it is usually given once daily for 3 to 7 days each week. Increasing product launches or product approvals by the regulatory authorities and an increase in the long term effect of growth hormone therapy on children with growth hormone deficiency are expected to fuel the growth of the global somatropin market over the forecast period.

Market Dynamics

Increasing product approval by regulatory authorities and an increase in the long term effect of growth hormone therapy on children with growth hormone deficiency is expected to fuel growth of the global somatropin market over the forecast period. For instance, in January, 2022, Ascendis Pharma A/S, a company that manufactures pharmaceutical products, announced that the European Commission (EC) granted marketing authorization for Lonapegsomatropin Ascendis Pharma (developed under the name TransCon hGH) as a once-weekly subcutaneous injection for the treatment of children and adolescents aged 3 to 18 years with growth failure due to insufficient secretion of endogenous growth hormone (also known as growth hormone deficiency, or GHD). TransCon hGH is a prodrug of somatropin that provides sustained release of unmodified somatropin (hGH) at predictable therapeutic levels in the body.

Key features of the study:

This report provides in-depth analysis of the global somatropin market, and provides market size (US$ Billion) and Compound Annual Growth Rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global somatropin market based on the following parameters-company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study are Novo Nordisk A/S, Pfizer, Inc., Eli Lilly and Company, Changchun GeneScience Pharmaceutical Co., Ltd., Sandoz International GmbH, Ipsen Pharma, LG Chem, Merck KGaA, Genentech, Inc., Ferring B.V., AnkeBio Co., Ltd, Reliance Life Sciences, JCR Pharmaceuticals Co., Ltd, Zhongshan Sinobioway Hygene Biomedicine Co., Ltd and USV Private Limited
Insights from this report will allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global somatropin market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global somatropin market

Detailed Segmentation:

Global Somatropin Market, By Dosage Form:
- Powder
- Solvent
Global Somatropin Market, By Application:
- Growth Hormone Deficiency (GHD)
- Turner Syndrome
- Chronic Renal Insufficiency
- Prader Willi Syndrome
- Small for Gestational Age
- SHOX Deficiency
- Others
Global Somatropin Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Somatropin Market, By Region:
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
Company Profiles
- Novo Nordisk A/S
- Pfizer, Inc.
- Eli Lilly and Company
- Changchun Gene Science Pharmaceutical Co., Ltd.
- Sandoz International GmbH
- Ipsen Pharma
- LG Chem
- Merck KGaA
- Genentech, Inc.
- Ferring B.V.
- AnkeBio Co., Ltd
- Reliance Life Sciences
- JCR Pharmaceuticals Co., Ltd
- Zhongshan Sinobioway Hygene Biomedicine Co., Ltd
- USV Private Limited

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Dosage Form
- Market Snapshot, By Application
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Merger, Acquisition, Collaborations
- Funding and Investment
- Product Approvals/Launches
- Regulatory Guidelines
- Key Developments
- PEST Analysis
- PORTER's Analysis

4. Global Somatropin Market- COVID-19 Impact Analysis

Economic Impact
COVID-19 Epidemiology
Impact on Supply and Demand

5. Global Somatropin Market, By Dosage Form, 2018-2030, (US$ Billion)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
Powder
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
Solvent
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

6. Global Somatropin Market, By Application, 2018-2030, (US$ Billion)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segments Trends
Growth Hormone Deficiency (GHD)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
Turner Syndrome
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
Chronic Renal Insufficiency
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
Prader Willi Syndrome
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
Small for Gestational Age
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
SHOX Deficiency
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

7. Global Somatropin Market, By Distribution Channel, 2018-2030, (US$ Billion)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segments Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

8. Global Somatropin Market, By Region, 2018-2030, (US$ Billion)

Introduction
- Market Share Analysis, By Region, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Region, 2018-2030
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018-2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Billion)
U.S.
Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018-2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Billion)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018-2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Billion)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018-2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Billion)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018-2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Billion)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018-2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Billion)
North Africa
Central Africa
South Africa

9. Competitive Landscape

Novo Nordisk A/S
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Pfizer, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Eli Lilly and Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Changchun GeneScience Pharmaceutical Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Sandoz International GmbH
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Ipsen Pharma
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
LG Chem
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Merck KGaA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Genentech, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Ferring B.V.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
AnkeBio Co., Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Reliance Life Sciences
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
JCR Pharmaceuticals Co., Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Zhongshan Sinobioway Hygene Biomedicine Co., Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
USV Private Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies

10. Section

Research Methodology
About Us

02-2729-4219

+886-2-2729-4219

License/价格

FAQ

生长激素市场:剂型，各用途，各流通管道，各地区-规模，占有率，展望，机会分析，2023年～2030年

Somatropin Market, By Dosage Form, By Application, By Distribution Channel, and By Region (North America, Latin America, Europe, Asia Pacific, Middle East and Africa)-Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

市场动态

本调查的主要特征

目录

第1章调查目的与前提条件

第2章市场概况

第3章市场动态，法规，趋势分析

第4章全球生长激素市场-COVID-19影响分析

第5章生长激素的全球市场:剂型，2018-2030年

第6章生长激素的全球市场:各用途，2018-2030年

第7章生长激素的全球市场:各流通管道，2018年～2030年

第8章生长激素的全球市场:各地区，2018-2030年

第9章竞争情形

第10章章节

Market Dynamics

Key features of the study:

Detailed Segmentation:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Somatropin Market- COVID-19 Impact Analysis

5. Global Somatropin Market, By Dosage Form, 2018-2030, (US$ Billion)

6. Global Somatropin Market, By Application, 2018-2030, (US$ Billion)

7. Global Somatropin Market, By Distribution Channel, 2018-2030, (US$ Billion)

8. Global Somatropin Market, By Region, 2018-2030, (US$ Billion)

9. Competitive Landscape

10. Section

生长激素市场:剂型，各用途，各流通管道，各地区-规模，占有率，展望，机会分析，2023年～2030年

Somatropin Market, By Dosage Form, By Application, By Distribution Channel, and By Region (North America, Latin America, Europe, Asia Pacific, Middle East and Africa)-Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

市场动态

本调查的主要特征

目录

第1章 调查目的与前提条件

第2章 市场概况

第3章 市场动态，法规，趋势分析

第4章 全球生长激素市场-COVID-19影响分析

第5章 生长激素的全球市场:剂型，2018-2030年

第6章 生长激素的全球市场:各用途，2018-2030年

第7章 生长激素的全球市场:各流通管道，2018年～2030年

第8章 生长激素的全球市场:各地区，2018-2030年

第9章 竞争情形

第10章 章节

Market Dynamics

Key features of the study:

Detailed Segmentation:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Somatropin Market- COVID-19 Impact Analysis

5. Global Somatropin Market, By Dosage Form, 2018-2030, (US$ Billion)

6. Global Somatropin Market, By Application, 2018-2030, (US$ Billion)

7. Global Somatropin Market, By Distribution Channel, 2018-2030, (US$ Billion)

8. Global Somatropin Market, By Region, 2018-2030, (US$ Billion)

9. Competitive Landscape

10. Section

第1章调查目的与前提条件

第2章市场概况

第3章市场动态，法规，趋势分析

第4章全球生长激素市场-COVID-19影响分析

第5章生长激素的全球市场:剂型，2018-2030年

第6章生长激素的全球市场:各用途，2018-2030年

第7章生长激素的全球市场:各流通管道，2018年～2030年

第8章生长激素的全球市场:各地区，2018-2030年

第9章竞争情形

第10章章节